XML 56 R38.htm IDEA: XBRL DOCUMENT v3.24.0.1
Business Segment and Geographic Data Information (Tables)
12 Months Ended
Dec. 31, 2023
Segment Reporting Information  
Information Concerning Consolidated Operations by Business Segment
Consolidated Operations by Business Segment
Year Ended December 31
202320222021
NET SALES(a)
Personal Care$10,691 $10,622 $10,267 
Consumer Tissue6,290 6,243 6,034 
K-C Professional3,404 3,256 3,072 
Corporate & Other46 54 67 
TOTAL NET SALES$20,431 $20,175 $19,440 
OPERATING PROFIT(b)
Personal Care$1,890 $1,787 $1,856 
Consumer Tissue976 806 888 
K-C Professional665 457 404 
Corporate & Other(c)
(1,118)(412)(559)
Other (income) and expense, net(d)
69 (43)28 
TOTAL OPERATING PROFIT$2,344 $2,681 $2,561 
(a)Net sales in the U.S. to third parties totaled $10,362, $9,848 and $9,285 in 2023, 2022 and 2021, respectively. No other individual country's net sales exceeds 10 percent of total net sales.
(b)    Segment operating profit excludes Other (income) and expense, net and income and expenses not associated with the business segments.
(c)    Corporate & Other in 2023 includes divestiture-related costs associated with the sale of our Brazil tissue and K-C Professional business of $30 and the charges related to the impairment of intangible assets of $658. In 2022, it includes transaction and integration costs of $21 related to the acquisition of a controlling interest in Thinx, and in 2021, it includes charges of $265 related to the 2018 Global Restructuring Program. Restructuring charges in 2021 related to the Personal Care, Consumer Tissue and K-C Professional business segments were $104, $118 and $40, respectively.
(d)    Other (income) and expense, net in 2023 includes the gain of $74 related to the sale of our Brazil tissue and K-C Professional business, and in 2022 includes the non-cash, non-recurring gain of $85 related to the acquisition of a controlling interest in Thinx.

Personal
Care
Consumer
Tissue
K-C
Professional
Corporate
& Other

Total
Depreciation and Amortization
2023$387 $236 $127 $3 $753 
2022375 251 125 754 
2021355 291 116 766 
Capital Spending
2023342 285 123 16 766 
2022442 280 142 12 876 
2021536 303 157 11 1,007 
Assets
20237,999 4,935 2,507 1,903 17,344 
20229,086 5,048 2,675 1,161 17,970 
20218,890 5,083 2,650 1,214 17,837 
Sales of Principal Products
Sales of Principal Products
(Billions of dollars)202320222021
Baby and child care products$7.1 $7.2 $7.2 
Consumer tissue products6.3 6.2 6.0 
Away-from-home professional products3.4 3.3 3.1 
All other3.6 3.5 3.1 
Consolidated$20.4 $20.2 $19.4